When platform processes are applied to fusion molecules, innovation and flexibility are needed.
Douglas W. Rea
Advertisement
Senior Specialist of Downstream Process Development at Laureate Pharma, Inc.
Articles by Douglas W. Rea
Advertisement
Latest Updated Articles
Solutions for Purification of Fc-fusion ProteinsPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
